Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.

PloS One
Amir M NiaFikret Er

Abstract

Antiarrhythmic action of flecainide is based on sodium channel blockade. Beta(1)-adrenoceptor (beta(1)AR) activation induces sodium channel inhibition, too. The aim of the present study was to evaluate the impact of different beta(1)AR genotypes on antiarrhythmic action of flecainide in patients with structural heart disease and atrial fibrillation. In 145 subjects, 87 with atrial fibrillation, genotyping was performed to identify the individual beta(1)AR Arg389Gly and Ser49Gly polymorphism. Resting heart rate during atrial fibrillation and success of flecainide-induced cardioversion were correlated with beta(1)AR genotype. The overall cardioversion rate with flecainide was 39%. The Arg389Arg genotype was associated with the highest cardioversion rate (55.5%; OR 3.30; 95% CI; 1.34-8.13; p = 0.003) compared to patients with Arg389Gly (29.5%; OR 0.44; 95% CI; 0.18-1.06; p = 0.066) and Gly389Gly (14%; OR 0.24; 95% CI 0.03-2.07; p = 0.17) variants. The single Ser49Gly polymorphism did not influence the conversion rate. In combination, patients with Arg389Gly-Ser49Gly genotype displayed the lowest conversion rate with 20.8% (OR 0.31; 95% CI; 0.10-0.93; p = 0.03). In patients with Arg389Arg variants the heart rate during atrial fibri...Continue Reading

References

Jun 1, 1989·The American Journal of Physiology·K OnoM Arita
Jul 3, 1986·The New England Journal of Medicine·D M Roden, R L Woosley
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Sep 3, 1998·The New England Journal of Medicine·M HaïssaguerreJ Clémenty
Apr 23, 1999·The Journal of Biological Chemistry·D A MasonS B Liggett
Apr 3, 2001·Annals of Internal Medicine·J M BrophyJ L Rouleau
Feb 20, 2002·JAMA : the Journal of the American Medical Association·JoAnne Micale FoodyHarlan M Krumholz
Feb 21, 2002·American Journal of Human Genetics·Koustubh RanadeNeil Risch
Feb 28, 2002·Lancet·Nicholas S PetersVias Markides
Jun 14, 2002·Cardiovascular Research·José JalifeMoussa Mansour
Aug 2, 2003·Journal of Cardiovascular Electrophysiology·Nathalie LalevéeSylvain Richard
Apr 2, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Keisuke ShiojiNaoharu Iwaii
Dec 3, 2004·The New England Journal of Medicine·Paolo AlboniGermano Gaggioli
Jul 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stephen B LiggettMichael R Bristow
Mar 6, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Thomas H Everett, Jeffrey E Olgin
Aug 4, 2007·Clinical Cardiology·Jana SlavíkováOndrej Topolcan
Mar 12, 2008·Circulation·Denis RoyUNKNOWN Atrial Arrhythmia Conversion Trial Investigators
May 9, 2009·British Journal of Pharmacology·Kirsten Leineweber, Gerd Heusch
Feb 25, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fikret ErStephan Rosenkranz
Apr 14, 2010·Genetic Testing and Molecular Biomarkers·Svetlana NicoulinaMikhail Voevoda

❮ Previous
Next ❯

Citations

Apr 18, 2013·Nature Reviews. Cardiology·Dawood Darbar, Dan M Roden
Feb 12, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Michael HuntgeburthStephan Rosenkranz
May 4, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Amir M NiaFikret Er
Mar 7, 2018·Expert Opinion on Emerging Drugs·Alessandro CapucciIrene Giannini
Sep 4, 2018·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kosuke Doki
Mar 5, 2016·Circulation. Arrhythmia and Electrophysiology·Colleen M HanleyPeter R Kowey
Jul 23, 2014·Circulation. Cardiovascular Genetics·Miklos D KertaiUNKNOWN Duke Perioperative Genetics and Safety Outcomes (PEGASUS) Investigative Team
Mar 3, 2020·Frontiers in Cardiovascular Medicine·Ahmed A Y RagabNatasja M S de Groot
Oct 6, 2020·Expert Opinion on Drug Discovery·Chun-Ka Wong, Hung-Fat Tse
May 22, 2021·Journal of the American College of Cardiology·John R GiudicessiJason C Kovacic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Peter MilbergLars Eckardt
© 2021 Meta ULC. All rights reserved